Quick Answer
Inspire Medical Systems, Inc. reported Cash And Cash Equivalents At Carrying Value of $104.81 million for the year ending 2025.
- Inspire Medical Systems, Inc. showed a decrease of -30.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Inspire Medical Systems, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $26.55 million | Q2 2017: $22.51 million | Q3 2017: $14.54 million | Q4 2017: $8.96 million | Q1 2018: $11.15 million | Q2 2018: $121.85 million | Q3 2018: $26.31 million | Q1 2019: $101.95 million | Q2 2019: $51.27 million | Q3 2019: $48.04 million | Q1 2020: $76.12 million | Q2 2020: $211.24 million | Q3 2020: $178.71 million | Q1 2021: $182.35 million | Q2 2021: $176.54 million | Q3 2021: $210.20 million | Q1 2022: $203.29 million | Q2 2022: $186.57 million | Q3 2022: $417.81 million | Q1 2023: $442.13 million | Q2 2023: $467.05 million | Q3 2023: $329.90 million | Q1 2024: $175.42 million | Q2 2024: $188.04 million | Q3 2024: $147.51 million | Q1 2025: $53.88 million | Q2 2025: $106.93 million | Q3 2025: $112.85 million.
- Over the full 11 years of available data (2015 to 2025), Inspire Medical Systems, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 764.4%.
- Historical annual values: Fiscal year 2025: $104.81 million | Fiscal year 2024: $150.15 million | Fiscal year 2023: $185.54 million | Fiscal year 2022: $441.59 million | Fiscal year 2021: $214.47 million | Fiscal year 2020: $190.52 million | Fiscal year 2019: $22.86 million | Fiscal year 2018: $97.29 million | Fiscal year 2017: $8.96 million | Fiscal year 2016: $6.69 million | Fiscal year 2015: $12.13 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: